IHC analysis demonstrated a progressive increase in SCNN1A and EFNA1 expression from adjacent non-tumor tissue to primary tumors and metastatic foci, with notably higher levels in subpopulations of tumor cells exhibiting a higher differentiation capacity. The gene discussed is EFNA1; the disease is neoplasm.